Beatrice Orso

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Structural MRI signature predicts tau staging in Alzheimer's disease.

Structural MRI signature predicts tau staging in Alzheimer's disease.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: May 08, 2026

Exploring the spatial covariance of cerebral vascular density and amyloid burden in Alzheimer's disease.

Exploring the spatial covariance of cerebral vascular density and amyloid burden in Alzheimer's disease.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: February 15, 2026

Shared Pathogenic Pathways Between REM Sleep Behavior Disorder and Neurodegenerative and Psychiatric Disorders.

Shared Pathogenic Pathways Between REM Sleep Behavior Disorder and Neurodegenerative and Psychiatric Disorders.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Shared Pathogenic Pathways Between REM Sleep Behavior Disorder and Neurodegenerative and Psychiatric Disorders.

Shared Pathogenic Pathways Between REM Sleep Behavior Disorder and Neurodegenerative and Psychiatric Disorders.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

MRI susceptibility map weighted imaging (SMWI) as a neurodegeneration biomarker in the prodromal to overt alpha-synucleinopathy continuum.

MRI susceptibility map weighted imaging (SMWI) as a neurodegeneration biomarker in the prodromal to overt alpha-synucleinopathy continuum.

Journal: Journal of Parkinson's disease

Published: December 03, 2025

Genetic associations between post-traumatic stress disorder and REM-sleep behavior disorder.

Genetic associations between post-traumatic stress disorder and REM-sleep behavior disorder.

Journal: NPJ Parkinson's disease

Published: November 20, 2025

[18F]Fluorodeoxyglucose positron emission tomography ([18F]FDG PET) Characterizes Neurodegeneration Levels Across the α-Synucleinopathy Continuum.

[18F]Fluorodeoxyglucose positron emission tomography ([18F]FDG PET) Characterizes Neurodegeneration Levels Across the α-Synucleinopathy Continuum.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: November 13, 2025

Sex differences in clinical and prognostic trajectories in patients with idiopathic REM sleep behavior disorder: Insights from the FARPRESTO cohort.

Sex differences in clinical and prognostic trajectories in patients with idiopathic REM sleep behavior disorder: Insights from the FARPRESTO cohort.

Journal: Journal of Parkinson's disease

Published: November 04, 2025

Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum.

Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum.

Journal: European journal of nuclear medicine and molecular imaging

Published: October 31, 2025

Correction: Magnetic susceptibility components reveal different aspects of neurodegeneration in alpha-synucleinopathies.

Correction: Magnetic susceptibility components reveal different aspects of neurodegeneration in alpha-synucleinopathies.

Journal: Scientific reports

Published: October 17, 2025

Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes.

Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes.

Journal: Journal of the American Heart Association

Published: October 14, 2025

Uncovering Clinical and Functional Neuroimaging Characteristics of Overt Stage Phenotypes Within the α-Synucleinopathy Spectrum.

Uncovering Clinical and Functional Neuroimaging Characteristics of Overt Stage Phenotypes Within the α-Synucleinopathy Spectrum.

Journal: Neurology

Published: October 10, 2025

Showing 1-12 of 58

Last Updated: 09/26/2026